A carregar...
Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA
Oral fostamatinib is an orally administered small molecule spleen tyrosine kinase (SYK) inhibitor approved for the treatment of adults with chronic immune thrombocytopenia (ITP) who have an inadequate response to a previous treatment. Fostamatinib has a unique mechanism of action, whereby its active...
Na minha lista:
| Publicado no: | Drugs Ther Perspect |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6223701/ https://ncbi.nlm.nih.gov/pubmed/30459507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40267-018-0551-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|